DEVELOPMENT, MARKETING AND CONSULTING AGREEMENTDevelopment, Marketing and Consulting Agreement • September 20th, 2016 • Med-X, Inc. • Pharmaceutical preparations • California
This Development, Marketing and Consulting Agreement (“Agreement”) is entered into on April 25, 2016, (“Effective Date”) by and between MEDX, Inc. (“MEDX”), a Nevada corporation, and M6, Ltd., a Private Limited Company based in London, United Kingdom (“M6”).
AMENDED AND RESTATED ENGAGEMENT LETTEREngagement Letter • September 20th, 2016 • Med-X, Inc. • Pharmaceutical preparations • Nevada
This amended and restated engagement letter (the “Agreement”) confirms the terms upon which Med-X, Inc. (the “Client”) engages Monarch Bay Securities, LLC (“MBS”, the “Placement Agent”). MBS is engaged to act as the exclusive Placement Agent to the Client in connection with a Regulation A+ Offering (as defined below) of securities on behalf of Client (the “Potential Transaction”). MBS is the “Financial Adviser,” which Client hereby engages upon signing this letter. This Agreement amends, restates and supersedes in its entirety that certain Engagement Letter dated July 27, 2016 between the Client and MBS (the “Original Letter”).
